The global intravenous (IV) equipment market size was estimated to be USD 14.57 billion in 2023 and is expected to reach USD 28.41 billion by 2034 with a CAGR of 6.26% during the forecast period 2024-2034. The rising prevalence of chronic diseases, rising technological advancements, increasing surgical procedures, the prevalence of infectious diseases, expansion of ambulatory care centers, government initiatives, and policies, and increasing awareness and education will drive market growth.
The increasing incidence of chronic conditions such as diabetes, cardiovascular diseases, and cancer has led to a growing demand for intravenous therapies for effective disease management. Ongoing technological innovations in IV equipment, including infusion pumps, catheters, and monitoring devices, enhance safety, precision, and ease of use. For instance, in 2023, Baxter International Inc. received FDA clearance for their PrismaFlex® Infinity System with Dose IQ, an innovative drug delivery system with intelligent dosage capabilities. partnered with Fresenius Medical Care in 2022 to create and market smart infusion pumps together.
By product, the infusion pumps segment accounted for the highest revenue-grossing segment in the global intravenous (IV) equipment market in 2023 owing to the increasing prevalence of chronic diseases requiring precise and controlled drug delivery, the rising adoption of ambulatory infusion pumps for home-based therapies, and continuous technological advancements that enhance the safety, accuracy, and user-friendliness of these devices. For instance, ICU Medical, Inc. acquired Neomed GmbH in 2023, strengthening its footprint in the European IV sector. In 2022, the ClearGuardTM PICC Plus Securement Device was introduced, which provides improved catheter stability. Additionally, the catheters segment is predicted to grow at the fastest CAGR during the forecast period owing to the escalating demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases and cancer necessitating long-term intravenous access, continuous advancements in catheter design and materials to enhance safety and efficacy, and the expanding application of catheters in both diagnostic and therapeutic medical interventions.
By end-user, the hospitals & clinics segment accounted for the highest revenue-grossing segment in the global intravenous (IV) equipment market in 2023 owing to the substantial patient influx in these healthcare settings, the increasing prevalence of acute and chronic diseases requiring intravenous therapies, the continuous expansion of hospital infrastructure globally, and the growing preference for inpatient care for severe medical conditions. For instance, in 2023, Terumo Corporation introduced the SurfacineTM PICC Catheter with ComfortGlideTM Technology, which enhances the patient experience and comfort during insertion. obtained CE Mark certification in 2022 for its integrated anesthetic delivery platform, Terumo Anesthesia System. Additionally, the homecare segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards patient-centric and cost-effective healthcare solutions, the rising prevalence of chronic diseases requiring long-term intravenous therapies, advancements in portable and user-friendly intravenous equipment suitable for home use, and the growing preference among patients for the comfort and convenience of receiving intravenous treatments in the home setting.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, a robust regulatory framework ensuring the adoption of advanced medical technologies, a high prevalence of chronic diseases necessitating intravenous therapies, and significant investments in research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure, a growing population, rising prevalence of chronic diseases, improving healthcare infrastructure, and a surge in awareness about advanced medical treatments. For instance, Smiths Medical introduced the Medevac 5700 Infusion Pump in September 2023, which offers improved data management and connection features for safer medicine administration and more efficient workflow.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
The increasing incidence of chronic conditions such as diabetes, cardiovascular diseases, and cancer has led to a growing demand for intravenous therapies for effective disease management. Ongoing technological innovations in IV equipment, including infusion pumps, catheters, and monitoring devices, enhance safety, precision, and ease of use. For instance, in 2023, Baxter International Inc. received FDA clearance for their PrismaFlex® Infinity System with Dose IQ, an innovative drug delivery system with intelligent dosage capabilities. partnered with Fresenius Medical Care in 2022 to create and market smart infusion pumps together.
By product, the infusion pumps segment accounted for the highest revenue-grossing segment in the global intravenous (IV) equipment market in 2023 owing to the increasing prevalence of chronic diseases requiring precise and controlled drug delivery, the rising adoption of ambulatory infusion pumps for home-based therapies, and continuous technological advancements that enhance the safety, accuracy, and user-friendliness of these devices. For instance, ICU Medical, Inc. acquired Neomed GmbH in 2023, strengthening its footprint in the European IV sector. In 2022, the ClearGuardTM PICC Plus Securement Device was introduced, which provides improved catheter stability. Additionally, the catheters segment is predicted to grow at the fastest CAGR during the forecast period owing to the escalating demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases and cancer necessitating long-term intravenous access, continuous advancements in catheter design and materials to enhance safety and efficacy, and the expanding application of catheters in both diagnostic and therapeutic medical interventions.
By end-user, the hospitals & clinics segment accounted for the highest revenue-grossing segment in the global intravenous (IV) equipment market in 2023 owing to the substantial patient influx in these healthcare settings, the increasing prevalence of acute and chronic diseases requiring intravenous therapies, the continuous expansion of hospital infrastructure globally, and the growing preference for inpatient care for severe medical conditions. For instance, in 2023, Terumo Corporation introduced the SurfacineTM PICC Catheter with ComfortGlideTM Technology, which enhances the patient experience and comfort during insertion. obtained CE Mark certification in 2022 for its integrated anesthetic delivery platform, Terumo Anesthesia System. Additionally, the homecare segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards patient-centric and cost-effective healthcare solutions, the rising prevalence of chronic diseases requiring long-term intravenous therapies, advancements in portable and user-friendly intravenous equipment suitable for home use, and the growing preference among patients for the comfort and convenience of receiving intravenous treatments in the home setting.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, a robust regulatory framework ensuring the adoption of advanced medical technologies, a high prevalence of chronic diseases necessitating intravenous therapies, and significant investments in research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure, a growing population, rising prevalence of chronic diseases, improving healthcare infrastructure, and a surge in awareness about advanced medical treatments. For instance, Smiths Medical introduced the Medevac 5700 Infusion Pump in September 2023, which offers improved data management and connection features for safer medicine administration and more efficient workflow.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Intravenous (IV) Equipment Market Report 2023 - 2034
Intravenous (IV) Equipment Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Infusion Pump
- Catheter
- Solution and Blood Administration Set
- Securement Device
- Cannula, Stopcock
- Needleless Connector
Intravenous (IV) Equipment Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals & Clinics
- Homecare
- Ambulatory Care Center
Intravenous (IV) Equipment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Intravenous (IV) Equipment Market: Product Estimates & Trend Analysis
8. Intravenous (IV) Equipment Market: End-User Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Intravenous (IV) Equipment Market
11. Europe Global Intravenous (IV) Equipment Market
12. Asia Pacific Global Intravenous (IV) Equipment Market
13. Latin America Global Intravenous (IV) Equipment Market
14. MEA Global Intravenous (IV) Equipment Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Cochlear Limited
- Medtronic plc
- Sonova Holding AG
- Advanced Bionics (a subsidiary of Sonova)
- Oticon Medical
- William Demant Holding A/S
- Nurotron Biotechnology Co. Ltd.
- Microson S.A.
- Neurelec (a subsidiary of William Demant)
- GN Hearing A/S
- Starkey Hearing Technologies
- Sivantos Pte. Ltd. (a part of WS Audiology)
- RION Co. Ltd.
- Cochlear Americas (a subsidiary of Cochlear Limited)
- Ototronix.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 14.57 Billion |
| Forecasted Market Value ( USD | $ 28.41 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
